Abstract
BackgroundData from the randomised placebo-controlled INBUILD trial in subjects with progressive fibrosing interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis suggested that nintedanib may have effects on circulating levels...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have